Compounds of formula (I), (II), and (III) having the structure shown below are presented: wherein R-R6 are defined herein. These molecules work as proteasome inhibitors and bind to the RPN13 subunit of the 19S regulatory particle, and can be used in methods of treating a condition or a disease, such as cancer, in a mammal.
化合物的结构如下所示,其
化学式为(I),(II),和(III),其中R-R6在此处定义。这些分子作为
蛋白酶体
抑制剂,并结合到19S调节粒子的R
PN13亚基,可用于治疗哺乳动物的疾病或病症,如癌症。